Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility

scientific article

Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...881736L
P356DOI10.1371/JOURNAL.PONE.0081736
P932PMC publication ID3842287
P698PubMed publication ID24312346
P5875ResearchGate publication ID259208713

P50authorMitesh DwivediQ49528729
Rasheedunnisa BegumQ56678847
P2093author name stringMohmmad Shoab Mansuri
Naresh C Laddha
Amina R Gani
P2860cites workThe genetics of generalized vitiligoQ37156257
Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligoQ37271641
Escape from "horror autotoxicus": pathogenesis and treatment of autoimmune diseaseQ40564157
Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.Q40647918
Vitiligo: where do we stand?Q40820967
Influence of inflammatory mediators and cytokines on human melanocyte functionQ40851442
Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in KoreansQ41138066
Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in VitiligoQ41144130
TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria.Q41453722
Cancer vaccines based on the identification of genes encoding cancer regression antigensQ41459252
The immune response in halo neviQ41621164
Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarctionQ44212606
Genetic epidemiology of vitiligo: a study of 815 probands and their families from south ChinaQ44626149
Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanismQ44663979
Association of catalase T/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat populationQ44708709
Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokinesQ44970678
Some disease-associated ancestral haplotypes carry a polymorphism of TNF.Q45081833
Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligoQ45196019
Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.Q45980503
Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population.Q46883159
Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in JapaneseQ47399276
Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cellsQ47733124
Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo.Q47879365
TNF, apoptosis and autoimmunity: a common thread?Q47913461
Genetic epidemiology of vitiligo: multilocus recessivity cross-validatedQ24672700
Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta productionQ24676008
Vitiligo: interplay between oxidative stress and immune systemQ26824504
Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control studyQ28199426
Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patientsQ28202292
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciencesQ29547562
The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and deathQ29620519
Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunityQ30415556
The common T60N polymorphism of the lymphotoxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndromeQ31149784
Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease.Q33759299
Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypesQ34360668
Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligoQ34533598
Vitiligo: a manifestation of apoptosis?Q34691252
Extreme genetic risk for type 1A diabetesQ35024527
Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions.Q35172185
Immunological pathomechanisms in vitiligo.Q35571087
MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosusQ35637001
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activationQ36082965
The pathophysiology of tumor necrosis factorsQ36135208
The genetic concept of vitiligoQ36248261
Cloning and expression of human lymphotoxin mRNA derived from a human T cell hybridomaQ36463453
Vitiligo: pathomechanisms and genetic polymorphism of susceptible genesQ36548616
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task ForceQ36717415
Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinentQ36767147
Autoimmune etiology of generalized vitiligo.Q37156254
Systemic lupus erythematosus and the extended major histocompatibility complex--evidence for several predisposing loci.Q50771222
Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients.Q50962031
Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.Q51050993
Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo.Q51075988
Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-a and TNF-0 by human mononuclear cells: a possible link to insulin-dependent diabetes mellitusQ53406543
Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.Q54314200
The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells.Q54324182
Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblastsQ54680714
Sex differences in autoimmune diseaseQ55970264
Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlationQ56898727
New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of LesionsQ58798285
HLA Alleles and Amino-Acid Signatures of the Peptide-Binding Pockets of HLA Molecules in VitiligoQ59323677
The polymorphisms of HLA-DR and TNF B loci in northern Chinese Han nationality and susceptibility to systemic lupus erythematosusQ64389217
Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokinesQ68092981
Usefulness of glycosylated recombinant human lymphotoxin for growth inhibition of human and murine solid tumors and experimental metastasis in miceQ70135080
Disease associations with complotypes, supratypes and haplotypesQ71686592
The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controlsQ71910677
Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligoQ72212397
Immunohistochemical studies from vitiligo--comparison between active and inactive lesionsQ72581546
Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cellsQ72624409
Pattern of familial aggregation of vitiligoQ72883023
Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosisQ73218951
Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean populationQ73350698
Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their familiesQ73406857
Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassayQ73470215
TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing diseaseQ73535233
Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphismQ73873232
Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokinesQ77636798
Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligoQ77748286
Cytokines in autoimmune disordersQ77894170
Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II moleculesQ78173467
Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotypeQ79073455
Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligoQ80392990
The genetics of generalized vitiligo and associated autoimmune diseasesQ80610906
The ACE gene I/ D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat populationQ81180881
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectvitiligoQ180152
P304page(s)e81736
P577publication date2013-11-27
P1433published inPLOS OneQ564954
P1476titleTumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility
P478volume8